Safety study of Niagen injections for fatigue
This trial tests whether Niagen injections are safe for people who feel tired. You would inject the study drug yourself at home for about three months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and generally healthy.
- You feel more tired than the average person (based on a short questionnaire).
- You have not had any NAD+ shots, IVs, or related products in the last 8 weeks.
- You are not anemic (your blood iron levels are normal).
- You are willing to give yourself daily shots under the skin and collect a few drops of blood from your finger.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests health and wellness products to see if they can improve fatigue and related health outcomes. You won't know if you're taking the real product or a placebo until the study ends.
This trial tests a natural supplement for fatigue in cancer survivors. You must have had fatigue for at least a month and be otherwise stable.
This study tests whether a wellness product can help improve fatigue and related health issues. You'll take either the real product or a placebo (a pill with no active ingredients) to see if it makes a difference.
This study tests whether a wellness product can help reduce fatigue and improve sports performance. You won't know if you're getting the product or a placebo until the end.
This study tests a health and wellness product to see if it helps improve fatigue and other women's health issues. You won't know if you get the real product or a placebo until the end.
This trial tests how well a new injectable form of Niagen (a supplement that may boost cellular energy) is absorbed and tolerated compared to NAD+. It may help if you are between 40 and 65, live near the study site, and feel unusually tired.
Hear when a new Fatigue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.